57 related articles for article (PubMed ID: 38644188)
1. [DIAGNOSIS OF GENETIC VARIANT CARRIERS IN A PATIENT WITH ASYMPTOMATIC BIRT-HOGG-DUBÉ SYNDROME: A CASE REPORT].
Watari S; Ichikawa T; Hirasawa A; Shiraishi H; Tokunaga M; Kubota R; Kusumi N; Tsushima T; Shinno Y; Furuya M
Nihon Hinyokika Gakkai Zasshi; 2023; 114(2):61-65. PubMed ID: 38644188
[TBL] [Abstract][Full Text] [Related]
2. Birt-Hogg-Dubé syndrome in an overall view: Focus on the clinicopathological prospects in renal tumors.
Wu J; Lu J; Wu CL; Lu M
Semin Diagn Pathol; 2024 May; 41(3):119-124. PubMed ID: 38242750
[TBL] [Abstract][Full Text] [Related]
3. A diagnosis of Birt-Hogg-Dubé syndrome in individuals with Smith-Magenis syndrome: Recommendation for cancer screening.
Vocke CD; Fleming LR; Piskorski AM; Amin A; Phornphutkul C; de la Monte S; Vilboux T; Duncan F; Pellegrino J; Braddock B; Middelton LA; Schmidt LS; Merino MJ; Cowen EW; Introne WJ; Linehan WM; Smith ACM
Am J Med Genet A; 2023 Feb; 191(2):490-497. PubMed ID: 36513625
[TBL] [Abstract][Full Text] [Related]
4. The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma.
Boris RS; Benhammou J; Merino M; Pinto PA; Linehan WM; Bratslavsky G
J Urol; 2011 Jun; 185(6):2050-5. PubMed ID: 21496834
[TBL] [Abstract][Full Text] [Related]
5. Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome.
Benhammou JN; Vocke CD; Santani A; Schmidt LS; Baba M; Seyama K; Wu X; Korolevich S; Nathanson KL; Stolle CA; Linehan WM
Genes Chromosomes Cancer; 2011 Jun; 50(6):466-77. PubMed ID: 21412933
[TBL] [Abstract][Full Text] [Related]
6. Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies.
Schmidt LS
Fam Cancer; 2013 Sep; 12(3):357-64. PubMed ID: 23108783
[TBL] [Abstract][Full Text] [Related]
7. Absence of the Birt-Hogg-Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility.
Preston RS; Philp A; Claessens T; Gijezen L; Dydensborg AB; Dunlop EA; Harper KT; Brinkhuizen T; Menko FH; Davies DM; Land SC; Pause A; Baar K; van Steensel MA; Tee AR
Oncogene; 2011 Mar; 30(10):1159-73. PubMed ID: 21057536
[TBL] [Abstract][Full Text] [Related]
8. The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development.
Baba M; Keller JR; Sun HW; Resch W; Kuchen S; Suh HC; Hasumi H; Hasumi Y; Kieffer-Kwon KR; Gonzalez CG; Hughes RM; Klein ME; Oh HF; Bible P; Southon E; Tessarollo L; Schmidt LS; Linehan WM; Casellas R
Blood; 2012 Aug; 120(6):1254-61. PubMed ID: 22709692
[TBL] [Abstract][Full Text] [Related]
9. BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genes.
Hasumi H; Furuya M; Tatsuno K; Yamamoto S; Baba M; Hasumi Y; Isono Y; Suzuki K; Jikuya R; Otake S; Muraoka K; Osaka K; Hayashi N; Makiyama K; Miyoshi Y; Kondo K; Nakaigawa N; Kawahara T; Izumi K; Teranishi J; Yumura Y; Uemura H; Nagashima Y; Metwalli AR; Schmidt LS; Aburatani H; Linehan WM; Yao M
Hum Mol Genet; 2018 Aug; 27(15):2712-2724. PubMed ID: 29767721
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.
Schmidt LS; Linehan WM
Nat Rev Urol; 2015 Oct; 12(10):558-69. PubMed ID: 26334087
[TBL] [Abstract][Full Text] [Related]
11. H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation.
Hasumi H; Hasumi Y; Baba M; Nishi H; Furuya M; Vocke CD; Lang M; Irie N; Esumi C; Merino MJ; Kawahara T; Isono Y; Makiyama K; Warner AC; Haines DC; Wei MH; Zbar B; Hagenau H; Feigenbaum L; Kondo K; Nakaigawa N; Yao M; Metwalli AR; Marston Linehan W; Schmidt LS
Hum Mol Genet; 2017 Jan; 26(2):354-366. PubMed ID: 28007907
[TBL] [Abstract][Full Text] [Related]
12. Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma.
Jikuya R; Johnson TA; Maejima K; An J; Ju YS; Lee H; Ha K; Song W; Kim Y; Okawa Y; Sasagawa S; Kanazashi Y; Fujita M; Imoto S; Mitome T; Ohtake S; Noguchi G; Kawaura S; Iribe Y; Aomori K; Tatenuma T; Komeya M; Ito H; Ito Y; Muraoka K; Furuya M; Kato I; Fujii S; Hamanoue H; Tamura T; Baba M; Suda T; Kodama T; Makiyama K; Yao M; Shuch BM; Ricketts CJ; Schmidt LS; Linehan WM; Nakagawa H; Hasumi H
EBioMedicine; 2023 Jun; 92():104596. PubMed ID: 37182269
[TBL] [Abstract][Full Text] [Related]
13. Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome.
Schmidt LS; Linehan WM
Expert Opin Orphan Drugs; 2015; 3(1):15-29. PubMed ID: 26581862
[TBL] [Abstract][Full Text] [Related]
14. Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.
Hasumi H; Baba M; Hasumi Y; Lang M; Huang Y; Oh HF; Matsuo M; Merino MJ; Yao M; Ito Y; Furuya M; Iribe Y; Kodama T; Southon E; Tessarollo L; Nagashima K; Haines DC; Linehan WM; Schmidt LS
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1624-31. PubMed ID: 25775561
[TBL] [Abstract][Full Text] [Related]
15. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2.
Hasumi Y; Baba M; Ajima R; Hasumi H; Valera VA; Klein ME; Haines DC; Merino MJ; Hong SB; Yamaguchi TP; Schmidt LS; Linehan WM
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18722-7. PubMed ID: 19850877
[TBL] [Abstract][Full Text] [Related]
16. TFEB and TFE3 drive kidney cystogenesis and tumorigenesis.
Di Malta C; Zampelli A; Granieri L; Vilardo C; De Cegli R; Cinque L; Nusco E; Pece S; Tosoni D; Sanguedolce F; Sorrentino NC; Merino MJ; Nielsen D; Srinivasan R; Ball MW; Ricketts CJ; Vocke CD; Lang M; Karim B; Lanfrancone L; Schmidt LS; Linehan WM; Ballabio A
EMBO Mol Med; 2023 May; 15(5):e16877. PubMed ID: 36987696
[TBL] [Abstract][Full Text] [Related]
17. Urticarial vasculitis and systemic symptoms as initial presentation of Birt-Hogg-Dubé syndrome: A case report.
Babalola O; Steinwehr D; Kanchustambham V
SAGE Open Med Case Rep; 2024; 12():2050313X241251759. PubMed ID: 38803360
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors.
Lang M; Vocke CD; Merino MJ; Schmidt LS; Linehan WM
Mod Pathol; 2015 Nov; 28(11):1458-69. PubMed ID: 26428318
[TBL] [Abstract][Full Text] [Related]
19. A retrospective cohort study of genetic referral and diagnosis of Birt-Hogg-Dubé Syndrome in patients with Trichodiscoma and Fibrofolliculoma skin lesions.
Shabet C; Kattapuram M; Burton A; Thoeny R; Nielsen H; Accardo ML; Smith EH; Koeppe E; Else T; Cha KB
Fam Cancer; 2024 Jun; ():. PubMed ID: 38822938
[TBL] [Abstract][Full Text] [Related]
20. Seventh BHD international symposium: recent scientific and clinical advancement.
Woodford MR; Andreou A; Baba M; van de Beek I; Di Malta C; Glykofridis I; Grimes H; Henske EP; Iliopoulos O; Kurihara M; Lazor R; Linehan WM; Matsumoto K; Marciniak SJ; Namba Y; Pause A; Rajan N; Ray A; Schmidt LS; Shi W; Steinlein OK; Thierauf J; Zoncu R; Webb A; Mollapour M
Oncotarget; 2022; 13():173-181. PubMed ID: 35070081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
